Join Arkis this year at booth 4900 of the AANS where we will be presenting Arkis’ new Tunneling Guidewire™ and the company’s plans for the launch of Endexo™ External Ventricular Drainage catheters. To learn more about the American Academy of Neurological Sciences, visit http://www.aans.org.
- Healthcare Professionals
- Healthcare Professionals
Arkis BioSciences News
Arkis is proud to have been selected for the NYVS this year and is scheduled to present June 24th in the conference’s Life Sciences round beginning at 10 AM EDT. We hope to see you there!
Arkis BioSciences completed FDA establishment registration Monday and listing of its Tunneling Guidewire instrument facilitating market introduction. Arkis’ Tunneling Guidewire now offers physicians and hydrocephalus patients a next generation surgical solution for less invasive shunt implantations, reducing neck incisions and surgical durations.
Join Arkis in the valley! Arkis selected to present among the nation’s Top 50 Innovators convening at Venture Summit West, San Francisco, February 10th-11th. Arkis will be presenting exciting news along with the latest updates of our commitment for revolutionizing patient care!
Arkis is honored to be invited to present at this year’s NY Venture Summit, June 23 – 24th, at The Digital Sandbox. Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.
Arkis will be sharing the latest company news at this year’s SEMDA annual conference for “Smart Devices + Smart Medicine” March 31st and April 1st, 2015 where we’ll be speaking about Arkis’ exclusive offering of its new FDA listed Tunneling Guidewire surgical instrument – the first of its kind for less invasive shunt procedures, as […]
Join Arkis at this year’s Southeastern Venture Conference where we’ll be presenting as a Top 50 Showcase Company in Charlotte, NC and sharing exciting news of Arkis’ latest offerings including its Tunneling Guidewire surgical instrument, providing less invasive shunt implantations!
Arkis presents at Tech-20/20’s Venture Exchange hosted by Pershing Yoakley & Associates P.C. March 21, 2013.
Arkis BioSciences is invited to SEMDA 2014, as CEO, Chad Seaver, presents Arkis’ latest developments. April 16, 2014.
Arkis BioSciences presents at LaunchTN’s Medical Device Venture Match hosted by the Provision Center for Proton Therapy and sponsorred by Bass Berry & Sims. February 25, 2014.
Advancing medical technology worldwide to improve the lives of people suffering from intracranial hypertension.
Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)
Arkis BioSciences is ISO 13485:2016 certified for its Medical Device Quality Management System by TUV USA, Inc. (Member of TUV NORD Group).